Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chemotherapy-Related Cognitive Impairment × Neuroprotective Agents × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Chemotherapy-Related Cognitive Impairment 1 Breast Neoplasms 1

Interventions

Cognitive Training 2 Vitamin D 1 Tobacco Use Cessation Devices 1 Synbiotics 1 Sodium Chloride 1 Saline Solution 1 Prebiotics 1 Neuroprotective Agents 1 Mesna 1 Magnetic Resonance Spectroscopy 1 High-Intensity Interval Training 1 Functional Status 1 Doxorubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05239663 2024-08-01

GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer

Sun Yat-sen University

Phase 3 Terminated

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡